Back
Catalyst Pharmaceuticals Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
71
CPRX
Catalyst Pharmaceuticals
Last Price:
$24.37
Seasonality Move:
17.09%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight buying pressure.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.41 | Buy |
| 20-day SMA: | 23.49 | Buy |
| 50-day SMA: | 23.14 | Buy |
| 200-day SMA: | 21.57 | Buy |
| 8-day EMA: | 23.59 | Buy |
| 20-day EMA: | 23.09 | Buy |
| 50-day EMA: | 18.74 | Buy |
| 200-day EMA: | 7.75 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.13 | Buy |
| Relative Strength Index (14 RSI): | 52.93 | Buy |
| Chaikin Money Flow: | 490263 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.44 - 24.08) | Buy |
| Bollinger Bands (100): | (21.49 - 23.85) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 23.78 while CPRX 8-day simple moving average is 23.41, which is a Buy signal.
-
The stock price of CPRX is 23.78 while Catalyst Pharmaceuticals 20-day SMA is 23.49, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day simple moving average is 23.14 while CPRX share price is 23.78, making it a Buy technically.
-
CPRX stock price is 23.78 and Catalyst Pharmaceuticals 200-day simple moving average is 21.57, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
71
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a BuyThe current Catalyst Pharmaceuticals [CPRX] share price is $23.78. The Score for CPRX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.9B
Price in USD:
23.78
Share Volume:
1M
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
26.16
52-Week Low:
14.75
Buy
71
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?The Catalyst Pharmaceuticals stock price is 23.78 USD today.
-
Will CPRX stock go up or go down?Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Catalyst Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 23.78 while CPRX 8-day exponential moving average is 23.59, which is a Buy signal.
-
The stock price of CPRX is 23.78 while Catalyst Pharmaceuticals 20-day EMA is 23.09, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day exponential moving average is 18.74 while CPRX share price is 23.78, making it a Buy technically.
-
CPRX stock price is 23.78 and Catalyst Pharmaceuticals 200-day simple moving average is 7.75, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.17 per share, an increase this year of $0.04 per share, and an increase next year of $0.25 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
-
CPRX Moving Average Covergence Divergence (MACD) indicator is 1.13, suggesting Catalyst Pharmaceuticals is a Buy
-
Catalyst Pharmaceuticals Relative Strength Index (RSI) is 52.93, which suggest Catalyst Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Catalyst Pharmaceuticals is (22.44 - 24.08), which suggest Catalyst Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Catalyst Pharmaceuticals is (21.49 - 23.85), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.